Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mining resistance genes of soybean cyst nematode based on genome-wide association study.

Frontiers in plant science·2026
Same author

Corrigendum to "Shengxian decoction mitigate bleomycin-induced pulmonary fibrosis in mice via MerTK mediated macrophage efferocytosis" [J. Ethnopharmacol. 365 (2026) 121583].

Journal of ethnopharmacology·2026
Same author

Efferocytosis enhances macrophage pro-angiogenic functions for bone marrow regeneration.

Cell death and differentiation·2026
Same author

Kernel PCA for out-of-Distribution Detection: Non-Linear Kernel Selection and Approximation.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

A novel noncanonical Src-mammalian STE20-like kinase 1 (MST1)-Akt/glycogen synthase kinase-3β (GSK3β) pathway drives platelet activation and thrombosis.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Hydrochar and pyrochar enhanced soil fungal community diversity in a <i>Quercus acutissima</i> plantation under severe nitric acid-type acid rain stress.

Frontiers in plant science·2026

Related Experiment Video

Updated: Jun 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Tanshinone IIA impairs platelet function and thrombus formation.

Wei Gu1, Haibo Hu1, Wei Zhu1

  • 1Department of Hematology, Xuzhou First People's Hospital and The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China.

Journal of Thrombosis and Haemostasis : JTH
|June 12, 2026
PubMed
Summary
This summary is machine-generated.

Tanshinone IIA inhibits platelet aggregation and thrombus formation by reducing reactive oxygen species and affecting key signaling proteins. This suggests its potential as a novel therapeutic for thrombotic diseases.

Keywords:
ROCK1plateletstalin1tanshinone IIAβ(3)

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 14, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Hemostasis and Thrombosis

Background:

  • Tanshinone IIA (T-IIA), derived from Danshen, has known cardioprotective effects.
  • Its precise impact on platelet function remains largely uncharacterized.

Purpose of the Study:

  • To elucidate the role of T-IIA in platelet aggregation, granule release, spreading, and clot retraction.
  • To assess T-IIA's effects on in vivo hemostasis and thrombus formation in a mouse model.

Main Methods:

  • Human platelets were treated with varying doses of T-IIA (10-100 μM) to assess functional changes.
  • Wild-type mice received T-IIA to evaluate hemostasis and thrombus development.
  • Proteomic and phosphoproteomic analyses were performed on stimulated platelets.

Main Results:

  • T-IIA dose-dependently inhibited platelet aggregation, ATP secretion, P-selectin expression, spreading, and clot retraction.
  • T-IIA administration prolonged bleeding time and reduced arterial/venous thrombosis in mice.
  • T-IIA suppressed platelet reactive oxygen species (ROS) generation and downregulated phosphorylation of ROCK1, p47phox, integrin β3, and talin1.

Conclusions:

  • Tanshinone IIA significantly impairs platelet function and thrombosis.
  • Inhibition occurs through multiple signaling pathways, including ROCK1/p47phox, β3, and talin1.
  • T-IIA shows promise as a therapeutic agent for thrombotic disorders.